This inventor holds 1 USPTO granted patent. Top assignee: Schweiz Serum & Impfinstitut Bern. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Thomas Hasler: Innovator in Polysaccharide Isolation
Introduction
Thomas Hasler is a notable inventor based in Bern, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the isolation of polysaccharides. His work is crucial for the development of vaccines, which play a vital role in public health.
Latest Patents
Hasler holds a patent for a method for the isolation of polysaccharides. This invention specifically addresses the separation of endotoxins from capsule polysaccharides of gram-negative bacteria. The polysaccharides isolated through this method are primarily utilized in the production of polysaccharide vaccines. Furthermore, the invention encompasses vaccines that contain polysaccharides isolated by the described method.
Career Highlights
Thomas Hasler is associated with the Schweiz Serum & Impfinstitut Bern, where he applies his expertise in biotechnology. His innovative approach to polysaccharide isolation has positioned him as a key figure in vaccine development.
Collaborations
Hasler collaborates with Emil Fürer, a fellow professional in the field. Their combined efforts contribute to advancements in vaccine technology and public health initiatives.
Conclusion
Thomas Hasler's work in polysaccharide isolation exemplifies the importance of innovation in biotechnology. His contributions are essential for the advancement of vaccine development and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile